This metabolic convergence is reflected, in clinical studies, by a body weight reduction of up to 24% in 48 weeks (Phase 2 data, NEJM 2023)
Together, these episodes explore how GLP-1 medications work, who theyre designed for, their potential benefits and risks, what were seeing both in practice and in the broader population, what the science says, and what active people need to know
Understanding your genetic predispositions in peptide pathways can support a more informed conversation with your provider about whether a lower-cost option like compounded oral semaglutide ($289/mo) might be effective for you, or whether a higher-potency alternative like compounded tirzepatide ($289/mo) offers better clinical value given your individual profile
adults, many unaware of their condition
Glue-Free Innovation for Faster, Cleaner Treatments Noemi Free Lift is the worlds first glue-free lifting system
Physical Activity and Metabolic Adaptation Framework Exercise supports weight loss through caloric expenditure, metabolic rate maintenance, and appetite regulation